BillionToOne, Inc.
Company Information
Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 1035 O'BRIEN DRIVE, MENLO PARK, CA,
Mailing Address 1035 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Phone 650-460-2551
Fiscal Year End 1231
EIN 811082020
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 13, 2026 | View on SEC |
| 3 Initial insider ownership report | January 20, 2026 | View on SEC |
| 4 Insider stock transaction report | January 20, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | January 20, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 3 Initial insider ownership report | January 5, 2026 | View on SEC |
| 10-Q Quarterly financial report | December 10, 2025 | View on SEC |
| 8-K Current report of material events | December 9, 2025 | View on SEC |
| 4 Insider stock transaction report | November 12, 2025 | View on SEC |
IPO Filings
S-1 October 7, 2025
- Advanced medical testing technology with 10x higher precision than competitors, focusing on prenatal and cancer diagnostics.
- Rapid revenue growth: 113% increase in 2024 ($152.6M) and 82% growth in first half of 2025 ($125.5M).
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.